We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$321M
AUM Growth
-$1.91M
Cap. Flow
-$7.11M
Cap. Flow %
-2.22%
Top 10 Hldgs %
65.16%
Holding
117
New
80
Increased
10
Reduced
16
Closed
11

Top Buys

1
MON
Monsanto Co
MON
+$23.3M
2
BIIB icon
Biogen
BIIB
+$17.5M
3
QGEN icon
Qiagen
QGEN
+$14.2M
4
BAC icon
Bank of America
BAC
+$11.7M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$10.8M

Top Sells

1
C icon
Citigroup
C
+$18.4M
2
GRA
W.R. Grace & Co.
GRA
+$13M
3
WLK icon
Westlake Corp
WLK
+$12.4M
4
SHPG
Shire pic
SHPG
+$11.8M
5
UBS icon
UBS Group
UBS
+$10.7M

Sector Composition

1 Healthcare 38.76%
2 Materials 25.39%
3 Financials 11.76%
4 Communication Services 7.23%
5 Energy 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$30.9M 9.63%
554,362
+34,226
+7% +$1.86M
MON
2
DELISTED
Monsanto Co
MON
$23.6M 7.36%
+199,510
New +$23.3M
GILD icon
3
Gilead Sciences
GILD
$167B
$23.6M 7.36%
333,602
+74,982
+29% +$4.99M
APD icon
4
Air Products & Chemicals
APD
$65.9B
$21.8M 6.81%
152,629
-47,389
-24% -$6.74M
QGEN icon
5
Qiagen
QGEN
$8.47B
$21.3M 6.63%
602,488
+421,054
+232% +$14.2M
GCP
6
DELISTED
GCP Applied Technologies Inc.
GCP
$19.3M 6.02%
633,179
+2,057
+0.3% +$64.7K
TIMB icon
7
TIM SA
TIMB
$10.6B
$19M 5.94%
1,286,336
-493,581
-28% -$7.62M
ASH icon
8
Ashland
ASH
$3.12B
$18.2M 5.69%
276,715
-52,114
-16% -$3.31M
BIIB icon
9
Biogen
BIIB
$30B
$17.9M 5.6%
+66,122
New +$17.5M
CELG
10
DELISTED
Celgene Corp
CELG
$13.2M 4.12%
101,756
-5,436
-5% -$666K
BAC icon
11
Bank of America
BAC
$428B
$12.1M 3.78%
+500,000
New +$11.7M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$11.3M 3.52%
+92,773
New +$10.8M
AXTA icon
13
Axalta
AXTA
$6.9B
$8.65M 2.7%
269,962
-57,995
-18% -$1.85M
FTI icon
14
TechnipFMC
FTI
$28.6B
$8.44M 2.63%
418,241
+297,383
+246% +$6.71M
C icon
15
Citigroup
C
$217B
$8.36M 2.61%
125,000
-299,244
-71% -$18.4M
OLN icon
16
Olin
OLN
$2.49B
$7.57M 2.36%
+250,053
New +$7.65M
WFC icon
17
Wells Fargo
WFC
$264B
$6.93M 2.16%
125,000
-155,970
-56% -$8.36M
DB icon
18
Deutsche Bank
DB
$67.2B
$5.67M 1.77%
319,821
+217,391
+212% +$3.85M
DBVT
19
DBV Technologies
DBVT
$868M
$5.11M 1.59%
14,300
+539
+4% +$184K
PCAR icon
20
PACCAR
PCAR
$66.1B
$4.77M 1.49%
108,440
+26,792
+33% +$1.16M
UBS icon
21
UBS Group
UBS
$173B
$4.24M 1.32%
250,000
-657,464
-72% -$10.7M
NXPI icon
22
NXP Semiconductors
NXPI
$67.5B
$2.34M 0.73%
+21,400
New +$2.29M
CVX icon
23
Chevron
CVX
$372B
$2.3M 0.72%
22,006
-8,037
-27% -$851K
HAL icon
24
Halliburton
HAL
$29.3B
$1.93M 0.6%
45,300
+2,720
+6% +$125K
LBTYA icon
25
Liberty Global Class A
LBTYA
$3.5B
$1.83M 0.57%
+56,986
New +$1.83M
1
2 3 4 5

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Exane Asset Management held 117 positions worth $321M, down 0.59% from $323M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Exane Asset Management's Q2 2017 filing shows 80 new, 10 increased, 16 reduced and 11 closed positions. Its largest new stake was Monsanto Co: 199,510 shares worth $23.6M. The largest sale was Citigroup, an estimated $18.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 26% a quarter earlier, followed by Materials and Financials.

  • Exane Asset Management's largest Q2 2017 buy was Monsanto Co: 199,510 shares worth $23.6M.
  • Exane Asset Management added most to Qiagen in Q2 2017, an estimated $14.2M increase.
  • Exane Asset Management's biggest Q2 2017 reduction was Citigroup, cutting an estimated $18.4M.
  • Exane Asset Management fully exited W.R. Grace & Co. in Q2 2017, selling an estimated $13M.
  • Exane Asset Management's ten largest holdings make up 65% of its $321M portfolio in Q2 2017.
  • Exane Asset Management opened 80 new positions and closed 11 in Q2 2017.
  • Exane Asset Management's portfolio value fell 0.59% quarter-over-quarter to $321M.

Based on Exane Asset Management's 13F filing for Q2 2017, filed 19 Jul 2017.